Cross Country Healthcares, Inc (NASDAQ:CCRN) currently has a daily average trading volume of 781.84K but it saw 329162 shares traded in last market. With a market cap of 355.50M USD, the company’s current market price of $10.80 came rising about 1.31 while comparing to the previous closing price of $10.66. In past 52 weeks, the stock remained buoying in the range of price level as high as $23.64 and as low as $9.58. In the recent trading on the day, stock has struck highest price mark of $10.69 while lowest mark touched by it was $11.24.
Taking a look at 20-day trading activity of Cross Country Healthcares, Inc (CCRN) gives us an average price of $10.79, while its current price level is -54.31% below from 52-week high level whereas it is 12.73% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $11.95 while that of 200 days or SMA-200 reads an average of $14.97. A closer look into the stock’s movement over the week reveals that its volatility is standing at 4.52% during that period while stretching the period over a month that increases to 5.73%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 46.35 which implies that the stock is in neutral territory.
Jefferies downgraded its recommendation for the stock as a “Hold” from “Buy” on November 03, 2023 while assigning a price target range of $32-$21.
Over the week, CCRN’s stock price is moving 5.78% up while it is -8.78% when we observe its performance for the past one month. Year-to-date it is -52.30% down and over the past year, the stock is showing a downside performance of -47.88%.
Currently, Cross Country Healthcares, Inc’s total number of outstanding shares is 34.38M. Company’s return on investment (ROI) stands at -0.41% and return on equity (ROE) at -0.39%. It has a 18.66 of forward P/E ratio. Stock’s beta reads 0.61. Stock has a price to book (P/B) ratio of 0.83 while price to sale or P/S ratio amounts to 0.25. Its return on asset (ROA) is -0.27% on average.
